Literature DB >> 24216124

Influence of age-related versus non-age-related renal dysfunction on survival in patients with left ventricular dysfunction.

Jeffrey M Testani1, Meredith A Brisco2, Gang Han3, Olga Laur4, Alexander J Kula4, Susan J Cheng4, Wai Hong Wilson Tang5, Chirag R Parikh6.   

Abstract

Normal aging results in a predictable decrease in glomerular filtration rate (GFR), and low GFR is associated with worsened survival. If this survival disadvantage is directly caused by the low GFR, as opposed to the disease causing the low GFR, the risk should be similar regardless of the underlying mechanism. Our objective was to determine if age-related decreases in estimated GFR (eGFR) carry the same prognostic importance as disease-attributable losses in patients with ventricular dysfunction. We analyzed the Studies Of Left Ventricular Dysfunction limited data set (n = 6,337). The primary analysis focused on determining if the eGFR-mortality relation differed by the extent to which the eGFR was consistent with normal aging. Mean eGFR was 65.7 ml/min/1.73 m(2) (SD = 19.0). Across the range of age in the population (27 to 80 years), baseline eGFR decreased by 0.67 ml/min/1.73 m(2)/year (95% confidence interval [CI] 0.63 to 0.71). The risk of death associated with eGFR was strongly modified by the degree to which the low eGFR could be explained by aging (p for interaction <0.0001). For example, in a model incorporating the interaction, uncorrected eGFR was no longer significantly related to mortality (adjusted hazard ratio 1.0 per 10 ml/min/1.73 m(2), 95% CI 0.97 to 1.1, p = 0.53), whereas a disease-attributable decrease in eGFR above the median carried significant risk (adjusted hazard ratio 2.8, 95% CI 1.6 to 4.7, p <0.001). In conclusion, in the setting of left ventricular dysfunction, renal dysfunction attributable to normal aging had a limited risk for mortality, suggesting that the mechanism underlying renal dysfunction is critical in determining prognosis.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24216124      PMCID: PMC3915785          DOI: 10.1016/j.amjcard.2013.09.029

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  25 in total

Review 1.  Cardiorenal syndrome: new perspectives.

Authors:  Jeremy S Bock; Stephen S Gottlieb
Journal:  Circulation       Date:  2010-06-15       Impact factor: 29.690

Review 2.  Ageing and the glomerular filtration rate: truths and consequences.

Authors:  Richard J Glassock; Christopher Winearls
Journal:  Trans Am Clin Climatol Assoc       Date:  2009

3.  Determinants of dynamic changes in serum creatinine in acute decompensated heart failure: the importance of blood pressure reduction during treatment.

Authors:  Matthias Dupont; Wilfried Mullens; Michael Finucan; David O Taylor; Randall C Starling; W H Wilson Tang
Journal:  Eur J Heart Fail       Date:  2013-01-02       Impact factor: 15.534

4.  Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure.

Authors:  Salim Yusuf; Bertram Pitt; Clarence E Davis; William B Hood; Jay N Cohn
Journal:  N Engl J Med       Date:  1991-08-01       Impact factor: 91.245

5.  Longitudinal studies on the rate of decline in renal function with age.

Authors:  R D Lindeman; J Tobin; N W Shock
Journal:  J Am Geriatr Soc       Date:  1985-04       Impact factor: 5.562

6.  Mortality risk stratification in chronic kidney disease: one size for all ages?

Authors:  Ann M O'Hare; Daniel Bertenthal; Kenneth E Covinsky; C Seth Landefeld; Saunak Sen; Kala Mehta; Michael A Steinman; Ann Borzecki; Louise C Walter
Journal:  J Am Soc Nephrol       Date:  2006-02-01       Impact factor: 10.121

7.  Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate.

Authors:  Andrew S Levey; Josef Coresh; Tom Greene; Lesley A Stevens; Yaping Lucy Zhang; Stephen Hendriksen; John W Kusek; Frederick Van Lente
Journal:  Ann Intern Med       Date:  2006-08-15       Impact factor: 25.391

8.  Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions.

Authors:  S Yusuf; B Pitt; C E Davis; W B Hood; J N Cohn
Journal:  N Engl J Med       Date:  1992-09-03       Impact factor: 91.245

9.  Elevated relative mortality risk with mild-to-moderate chronic kidney disease decreases with age.

Authors:  Neil T Raymond; Daniel Zehnder; Stephen C H Smith; Julie A Stinson; Hendrik Lehnert; Robert M Higgins
Journal:  Nephrol Dial Transplant       Date:  2007-07-12       Impact factor: 5.992

Review 10.  Cardiorenal syndrome.

Authors:  Claudio Ronco; Mikko Haapio; Andrew A House; Nagesh Anavekar; Rinaldo Bellomo
Journal:  J Am Coll Cardiol       Date:  2008-11-04       Impact factor: 24.094

View more
  5 in total

Review 1.  Novel renal biomarkers to assess cardiorenal syndrome.

Authors:  Meredith A Brisco; Jeffrey M Testani
Journal:  Curr Heart Fail Rep       Date:  2014-12

2.  Effect of renal function on prognosis in chronic heart failure.

Authors:  Adrián Ignacio Löffler; Thomas P Cappola; James Fang; Scott J Hetzel; Andrew Kadlec; Brad Astor; Nancy K Sweitzer
Journal:  Am J Cardiol       Date:  2014-10-23       Impact factor: 2.778

3.  The Impact of Donor and Recipient Renal Dysfunction on Cardiac Allograft Survival: Insights Into Reno-Cardiac Interactions.

Authors:  Olga Laur; Meredith A Brisco; Alexander J Kula; Susan J Cheng; Abeel A Mangi; Lavanya Bellumkonda; Daniel L Jacoby; Steven Coca; W H Wilson Tang; Chirag R Parikh; Jeffrey M Testani
Journal:  J Card Fail       Date:  2015-11-23       Impact factor: 5.712

Review 4.  [Renal replacement therapy in the elderly].

Authors:  R Schindler
Journal:  Z Gerontol Geriatr       Date:  2016-07-21       Impact factor: 1.281

5.  Development of a prediction model for mortality and cardiovascular outcomes in older adults taking into account AZGP1.

Authors:  Elke Schaeffner; Roland Schmitt; Dörte Huscher; Natalie Ebert; Inga Soerensen-Zender; Nina Mielke
Journal:  Sci Rep       Date:  2021-06-03       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.